Zavante Therapeutics, Inc. — Form D
Zavante Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-15. The offering totals $14K, of which $14K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-05-15
- Form: D
- Accession: 0001140361-15-020271
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $14K
- Amount sold: $14K
- Investors: 7
- Date of first sale: 2015-05-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-240038
Issuer
- Name: Zavante Therapeutics, Inc.
- CIK: 0001642422
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 12670 High Bluff Drive, SAN DIEGO, CA, 92130
- Phone: (858) 523-5400
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Cam L Garner | Director | San Diego, CA |
| Cam L Garner | Executive Officer | San Diego, CA |
| Theodore R Schroeder | Director | San Diego, CA |
| Theodore R Schroeder | Executive Officer | San Diego, CA |
| Cam R Gallagher | Executive Officer | San Diego, CA |
| Patrick L Heron | Director | San Diego, CA |
| Kevin L Finney | Executive Officer | San Diego, CA |
| Cam L Gallagher | Executive Officer | San Diego, CA |
| David L Hirsch | Director | San Diego, CA |
| Evelyn J Ellis-Grosse | Executive Officer | San Diego, CA |
| Cam R Garner | Director | San Diego, CA |
| Cam R Garner | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More